Hypofractionated radiotherapy in the real-world setting: an international ESTRO-GIRO survey

Background and purpose - Multiple large trials have established the non-inferiority of hypofractionated radiotherapy compared to conventional fractionation. This study will determine real-world hypofractionation adoption across different geographic regions for breast, prostate, cervical cancer, and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Rodin, Danielle (VerfasserIn) , Tawk, Bouchra (VerfasserIn) , Mohamad, Osama (VerfasserIn) , Grover, Surbhi (VerfasserIn) , Moraes, Fabio Y. (VerfasserIn) , Yap, Mei Ling (VerfasserIn) , Zubizarreta, Eduardo (VerfasserIn) , Lievens, Yolande (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 14 January 2021
In: Radiotherapy and oncology
Year: 2021, Jahrgang: 157, Pages: 32-39
ISSN:1879-0887
DOI:10.1016/j.radonc.2021.01.003
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.radonc.2021.01.003
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0167814021000037
Volltext
Verfasserangaben:Danielle Rodin, Bouchra Tawk, Osama Mohamad, Surbhi Grover, Fabio Y. Moraes, Mei Ling Yap, Eduardo Zubizarreta, Yolande Lievens

MARC

LEADER 00000caa a2200000 c 4500
001 1760549339
003 DE-627
005 20240413193535.0
007 cr uuu---uuuuu
008 210616s2021 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.radonc.2021.01.003  |2 doi 
035 |a (DE-627)1760549339 
035 |a (DE-599)KXP1760549339 
035 |a (OCoLC)1341416437 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Rodin, Danielle  |e VerfasserIn  |0 (DE-588)1235535487  |0 (DE-627)1760550329  |4 aut 
245 1 0 |a Hypofractionated radiotherapy in the real-world setting  |b an international ESTRO-GIRO survey  |c Danielle Rodin, Bouchra Tawk, Osama Mohamad, Surbhi Grover, Fabio Y. Moraes, Mei Ling Yap, Eduardo Zubizarreta, Yolande Lievens 
264 1 |c 14 January 2021 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 16.06.2021 
520 |a Background and purpose - Multiple large trials have established the non-inferiority of hypofractionated radiotherapy compared to conventional fractionation. This study will determine real-world hypofractionation adoption across different geographic regions for breast, prostate, cervical cancer, and bone metastases, and identify barriers and facilitators to its use. - Materials and methods - An anonymous, electronic survey was distributed from January 2018 through January 2019 to radiation oncologists through the ESTRO-GIRO initiative. Predictors of hypofractionation were identified in univariable and multivariable regression analyses. - Results - 2316 radiation oncologists responded. Hypofractionation was preferred in node-negative breast cancer following lumpectomy (82·2% vs. 46·7% for node-positive; p < 0.001), and in low- and intermediate-risk prostate cancer (57·5% and 54·5%, respectively, versus 41·2% for high-risk (p < 0.001)). Hypofractionation was used in 32·3% of cervix cases in Africa, but <10% in other regions (p < 0.001). For palliative indications, hypofractionation was preferred by the majority of respondents. Lack of long-term data and concerns about local control and toxicity were the most commonly cited barriers. In adjusted analyses, hypofractionation was least common for curative indications amongst low- and lower-middle-income countries, Asia-Pacific, female respondents, small catchment areas, and in centres without access to intensity modulated radiotherapy. - Conclusion - Significant variation was observed in hypofractionation across curative indications and between regions, with greater concordance in palliation. Using inadequate fractionation schedules may impede the delivery of affordable and accessible radiotherapy. Greater regionally-targeted and disease-specific education on evidence-based fractionation schedules is needed to improve utilization, along with best-case examples addressing practice barriers and supporting policy reform. 
650 4 |a Breast neoplasms 
650 4 |a Dose fractionation 
650 4 |a Global health 
650 4 |a Prostatic neoplasms 
650 4 |a Radiotherapy 
650 4 |a Uterine cervical neoplasms 
700 1 |a Tawk, Bouchra  |e VerfasserIn  |0 (DE-588)1210567857  |0 (DE-627)1698621531  |4 aut 
700 1 |a Mohamad, Osama  |e VerfasserIn  |4 aut 
700 1 |a Grover, Surbhi  |e VerfasserIn  |4 aut 
700 1 |a Moraes, Fabio Y.  |e VerfasserIn  |4 aut 
700 1 |a Yap, Mei Ling  |e VerfasserIn  |4 aut 
700 1 |a Zubizarreta, Eduardo  |e VerfasserIn  |4 aut 
700 1 |a Lievens, Yolande  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Radiotherapy and oncology  |d Amsterdam [u.a.] : Elsevier Science, 1983  |g 157(2021), Seite 32-39  |h Online-Ressource  |w (DE-627)306710110  |w (DE-600)1500707-8  |w (DE-576)082435731  |x 1879-0887  |7 nnas  |a Hypofractionated radiotherapy in the real-world setting an international ESTRO-GIRO survey 
773 1 8 |g volume:157  |g year:2021  |g pages:32-39  |g extent:8  |a Hypofractionated radiotherapy in the real-world setting an international ESTRO-GIRO survey 
856 4 0 |u https://doi.org/10.1016/j.radonc.2021.01.003  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0167814021000037  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210616 
993 |a Article 
994 |a 2021 
998 |g 1210567857  |a Tawk, Bouchra  |m 1210567857:Tawk, Bouchra  |d 910000  |d 911400  |e 910000PT1210567857  |e 911400PT1210567857  |k 0/910000/  |k 1/910000/911400/  |p 2 
999 |a KXP-PPN1760549339  |e 3938713410 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1760549339","language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 16.06.2021"],"person":[{"role":"aut","roleDisplay":"VerfasserIn","display":"Rodin, Danielle","given":"Danielle","family":"Rodin"},{"given":"Bouchra","family":"Tawk","role":"aut","roleDisplay":"VerfasserIn","display":"Tawk, Bouchra"},{"role":"aut","display":"Mohamad, Osama","roleDisplay":"VerfasserIn","given":"Osama","family":"Mohamad"},{"family":"Grover","given":"Surbhi","roleDisplay":"VerfasserIn","display":"Grover, Surbhi","role":"aut"},{"given":"Fabio Y.","family":"Moraes","role":"aut","roleDisplay":"VerfasserIn","display":"Moraes, Fabio Y."},{"role":"aut","display":"Yap, Mei Ling","roleDisplay":"VerfasserIn","given":"Mei Ling","family":"Yap"},{"family":"Zubizarreta","given":"Eduardo","display":"Zubizarreta, Eduardo","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Lievens","given":"Yolande","roleDisplay":"VerfasserIn","display":"Lievens, Yolande","role":"aut"}],"title":[{"title_sort":"Hypofractionated radiotherapy in the real-world setting","title":"Hypofractionated radiotherapy in the real-world setting","subtitle":"an international ESTRO-GIRO survey"}],"relHost":[{"title":[{"title_sort":"Radiotherapy and oncology","subtitle":"journal of the European Society for Therapeutic Radiology and Oncology","title":"Radiotherapy and oncology"}],"disp":"Hypofractionated radiotherapy in the real-world setting an international ESTRO-GIRO surveyRadiotherapy and oncology","note":["Gesehen am 30.05.15","Ungezählte Beil.: Supplement"],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"recId":"306710110","pubHistory":["1.1983 -"],"titleAlt":[{"title":"The green journal"}],"part":{"year":"2021","pages":"32-39","volume":"157","text":"157(2021), Seite 32-39","extent":"8"},"origin":[{"publisherPlace":"Amsterdam [u.a.]","dateIssuedDisp":"1983-","publisher":"Elsevier Science","dateIssuedKey":"1983"}],"id":{"zdb":["1500707-8"],"eki":["306710110"],"issn":["1879-0887"]},"physDesc":[{"extent":"Online-Ressource"}]}],"physDesc":[{"extent":"8 S."}],"name":{"displayForm":["Danielle Rodin, Bouchra Tawk, Osama Mohamad, Surbhi Grover, Fabio Y. Moraes, Mei Ling Yap, Eduardo Zubizarreta, Yolande Lievens"]},"id":{"eki":["1760549339"],"doi":["10.1016/j.radonc.2021.01.003"]},"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"14 January 2021"}]} 
SRT |a RODINDANIEHYPOFRACTI1420